Join FREE Newsletter

My Account Logout Contact Us Subscribe Now! Login Contact Us
Home Product Tests  Warnings  Encyclopedia News Where to Buy
 
 

Recalls and Warnings

 RECENT RECALLS AND WARNINGS
Seller of Aloe, Prostate and Joint Supplements Warned for Manufacturing Violations

Seller of Herbal Formulas for Cholesterol, Prostate & More Warned For Drug Claims

Seller on Noni Juice Warned for Manufacturing Violations, Drug Claims

Kratom To Be Classified a Schedule I Controlled Substance

Past Recalls and Warnings

 REPORT A PROBLEM
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem.
Latest News:  Memory Enhancement Ingredient Vinpocetine Should Not Be Sold In Supplements, Says FDA
(Date Posted: 9/16/2016)

On September 7, 2016, the FDA announced its tentative conclusion that the synthetic compound vinpocetine, currently sold in some dietary supplements, should not be classified as a dietary supplement ingredient. The agency is seeking comments for consideration as it works to make a final decision on the regulatory status of the chemical.

Vinpocetine is produced by chemically altering a compound found in periwinkle (Vinca minor L.). In the U.S. vinpocetine is currently sold as an ingredient in dietary supplements promoted to improve memory and cognition function, such as Procera AVH, and is sometimes added to Gingko biloba supplements. (Note: In 2015, a study of 23 supplements sold in the U.S. which listed vinpocetine as an ingredient found six did not contain any vinpocetine. Among those that did contain vinpocetine, most did not list amounts on the label -- see the Warning for more information about the study).

However, in its statement, the FDA noted that vinpocetine is "not an herb or other botanical, nor is it a constituent of any botanical," and does not meet the definition of a dietary ingredient." In Europe, vinpocetine is sold as a prescription drug. 

Since 1997, the FDA has received, and not objected to, five new dietary ingredient notifications (NDIs) for vinpocetine. However, if the FDA decides that vinpocetine does not meet the definition of a dietary ingredient, it will no longer be permitted to be sold in supplements.

(See the Encyclopedia article about Vinpocetine for more information. Also see the Review of Ginkgo Biloba Supplements for tests of related products).

To read the FDA's notice, use the red link below.

https://www.federalregister.gov/documents/2016/09/07/2016-21350/request-for-comment-on-the-status-of-vinpocetine

Archive of Recent Recalls and Warnings


 

Follow us on...
   

ConsumerLab.com Encyclopedia

In addition to our product reviews our encyclopedia covers the following:



Follow ConsumerLab.com on Twitter    |     Become a Fan on Facebook
Join | Sign In
Home | Product Tests | Brands Tested | Health Conditions | Encyclopedia | CL Answers | Clinical Updates | Where to Buy Products
News | Recalls & Warnings | RDAs | Raw Materials Tests | Testing Programs | The CL Seal | CL Survey | About Us
In The News | Group Subscription | Gift Memberships | Join Free Newsletter | Privacy Policy | Site Map | Testimonials | Contact Us/Help

©2016 ConsumerLab.com, LLC. All rights reserved. A single copy of a report may be printed for personal use by the subscriber.
It is otherwise unlawful to print, download, store or distribute content from this site without permission.
ConsumerLab.com name and flask logo are both registered trademarks of ConsumerLab.com, LLC.
This site is intended for informational purposes only and not to provide medical advice.